{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:40:21Z","timestamp":1756291221047,"version":"3.44.0"},"reference-count":20,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,12,26]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>An 80-year-old, previously healthy patient presents with acute transverse myelitis with sensory level at T8. The MRI scan of the spinal cord showed longitudinal extensive transverse myelitis, and she tested positive for aquaporin 4 antibodies in serum. She received treatment with intravenous and oral steroids, with no improvement and then underwent plasma exchange. She was then started on azathioprine for prevention of relapses, while continuing physiotherapy and occupational therapy. Eventually, she was transferred to a specialised spinal cord centre for long-term rehabilitation.<\/jats:p>","DOI":"10.1136\/bcr-2020-238992","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T12:37:55Z","timestamp":1611751075000},"page":"e238992","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Neuromyelitis optica spectrum disorder (NMOSD) presenting as acute transverse myelitis with positive aquaporin 4 antibodies"],"prefix":"10.1136","volume":"14","author":[{"given":"Katherine","family":"Thornley","sequence":"first","affiliation":[{"name":"General Medicine, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Canepa","sequence":"additional","affiliation":[{"name":"Stroke and Neurology, James Paget University Hospital NHS Foundation Trust, Great Yarmouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"2025082703171283000_14.1.e238992.1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"2025082703171283000_14.1.e238992.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.07.025"},{"key":"2025082703171283000_14.1.e238992.3","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","article-title":"Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies","volume":"70","author":"Kitley","year":"2013","journal-title":"JAMA Neurol"},{"key":"2025082703171283000_14.1.e238992.4","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1019132"},{"key":"2025082703171283000_14.1.e238992.5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","article-title":"Inflammatory demyelinating diseases of the central nervous system","volume":"145","author":"H\u00f6ftberger","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"2025082703171283000_14.1.e238992.6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/WNO.0000000000000508","article-title":"Neuromyelitis optica: deciphering a complex immune-mediated Astrocytopathy","volume":"37","author":"Bennett","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"2025082703171283000_14.1.e238992.7","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-2-169"},{"key":"2025082703171283000_14.1.e238992.8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"2025082703171283000_14.1.e238992.9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1032"},{"key":"2025082703171283000_14.1.e238992.10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/biomedicines7020042","article-title":"Neuromyelitis optica spectrum disorder and anti-MOG syndromes","volume":"7","author":"Lana-Peixoto","year":"2019","journal-title":"Biomedicines"},{"key":"2025082703171283000_14.1.e238992.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001367"},{"key":"2025082703171283000_14.1.e238992.12","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-6-s53"},{"key":"2025082703171283000_14.1.e238992.13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"2025082703171283000_14.1.e238992.14","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00888","article-title":"Diagnosis and treatment of NMO spectrum disorder and MOG-Encephalomyelitis","volume":"9","author":"Borisow","year":"2018","journal-title":"Front Neurol"},{"key":"2025082703171283000_14.1.e238992.15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jocn.2015.01.028","article-title":"Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica","volume":"22","author":"Qiu","year":"2015","journal-title":"J Clin Neurosci"},{"key":"2025082703171283000_14.1.e238992.16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31822a2780"},{"key":"2025082703171283000_14.1.e238992.17","first-page":"30033","article-title":"Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders","volume":"213","author":"Carre\u00f3n Guarnizo","year":"2019","journal-title":"Neurologia"},{"key":"2025082703171283000_14.1.e238992.18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00415-015-7766-8","article-title":"Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75","volume":"262","author":"Krumbholz","year":"2015","journal-title":"J Neurol"},{"key":"2025082703171283000_14.1.e238992.19","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513515085"},{"key":"2025082703171283000_14.1.e238992.20","doi-asserted-by":"crossref","first-page":"100021","DOI":"10.1016\/j.lanwpc.2020.100021","article-title":"Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study","volume":"2","author":"Tian","year":"2020","journal-title":"Lancet Reg Health -West Pacific"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-238992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:17:19Z","timestamp":1756289839000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-238992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,27]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bcr-2020-238992"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-238992","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}